{"abdominal discomfort": 9.8, "adjustment disorder with depressed mood": 60.93, "adrenal insufficiency": 5.2, "adverse drug reaction": 6.97, "adverse event": 3.95, "adverse reaction": 8.48, "alanine aminotransferase abnormal": 8.68, "alopecia": 9.22, "amnesia": 2.15, "anal abscess": 4.52, "anal fistula": 7.96, "ankle arthroplasty": 106.86, "ankylosing spondylitis": 2.55, "anti-cyclic citrullinated peptide antibody": 401.34, "anti-cyclic citrullinated peptide antibody positive": 200.74, "antibody test positive": 29.59, "arthritis": 7.35, "arthritis bacterial": 3.04, "arthropathy": 32.01, "autoimmune disorder": 13.71, "back disorder": 4.19, "back injury": 10.64, "basal cell carcinoma": 7.7, "blepharospasm": 13.36, "blister": 6.83, "blood cholesterol increased": 16.16, "blood parathyroid hormone decreased": 56.31, "body height below normal": 183.51, "bone erosion": 39.28, "breast cancer stage ii": 3.34, "breast cancer stage iii": 12.47, "bronchiectasis": 9.31, "burns second degree": 8.69, "bursitis": 27.17, "c-reactive protein": 192.1, "c-reactive protein abnormal": 106.55, "c-reactive protein increased": 11.37, "catarrh": 4.59, "chronic sinusitis": 15.38, "coeliac disease": 11.79, "colitis": 2.89, "colitis ulcerative": 7.77, "condition aggravated": 4.5, "confusional state": 2.33, "contraindicated product administered": 41.45, "contusion": 2.67, "crohn's disease": 11.04, "cushingoid": 4.52, "cyst": 2.16, "dactylitis": 18.76, "deep vein thrombosis postoperative": 319.65, "deformity": 6.92, "delirium": 2.01, "diarrhoea haemorrhagic": 2.31, "disability": 6.05, "discomfort": 10.77, "dislocation of vertebra": 104.88, "disseminated tuberculosis": 17.11, "drug eruption": 2.81, "drug hypersensitivity": 7.76, "drug ineffective": 4.13, "drug ineffective for unapproved indication": 2.89, "drug intolerance": 16.5, "drug specific antibody": 24.16, "drug specific antibody present": 30.31, "drug tolerance": 27.37, "drug tolerance decreased": 51.67, "drug-induced liver injury": 3.06, "dry mouth": 2.03, "duodenal ulcer perforation": 140.6, "dyspepsia": 3.02, "ear infection": 2.32, "enthesopathy": 37.82, "exostosis": 10.42, "exposure during pregcy": 3.25, "eye injury": 13.82, "facet joint syndrome": 189.11, "faecal calprotectin increased": 24.74, "fear of injection": 7.04, "female genital tract fistula": 21.66, "femur fracture": 2.52, "fibromyalgia": 18.06, "finger deformity": 16.24, "folliculitis": 44.24, "foot deformity": 12.68, "foot operation": 7.64, "fracture delayed union": 53.49, "frequent bowel movements": 8.54, "gait inability": 2.97, "gastroenteritis viral": 7.52, "gastrointestinal disorder": 4.87, "gastrointestinal inflammation": 3.24, "general physical health deterioration": 5.27, "gingival pain": 2.06, "glossodynia": 51.79, "granuloma skin": 61.43, "grip strength decreased": 15.67, "haematocrit decreased": 2.28, "hand deformity": 113.84, "helicobacter infection": 61.12, "hepatic cirrhosis": 2.12, "hepatic enzyme increased": 4.95, "hepatitis": 2.08, "hepatosplenic t-cell lymphoma": 40.67, "hepatotoxicity": 2.12, "hidradenitis": 37.34, "hip arthroplasty": 6.55, "hodgkin's disease": 4.52, "human antichimeric antibody positive": 322.89, "hypercalcaemia": 4.58, "hypercholesterolaemia": 6.6, "hypersensitivity": 2.2, "hypocalcaemia": 5.16, "hypopnoea": 2.71, "ill-defined disorder": 9.68, "immunodeficiency": 9.95, "impaired healing": 16.1, "impaired quality of life": 10.0, "infection": 4.01, "inflammation": 6.76, "inflammatory bowel disease": 2.97, "inflammatory marker increased": 4.44, "infusion related reaction": 16.51, "infusion site reaction": 9.4, "injury": 5.33, "intentional product use issue": 7.55, "iridocyclitis": 2.26, "irritable bowel syndrome": 13.66, "joint destruction": 98.11, "joint dislocation": 4.3, "joint effusion": 4.01, "joint injury": 3.83, "joint range of motion decreased": 11.54, "joint stiffness": 3.54, "joint swelling": 8.11, "juvenile idiopathic arthritis": 28.97, "knee arthroplasty": 5.02, "laryngitis": 2.53, "limb deformity": 13.35, "lip dry": 9.5, "live birth": 9.92, "liver function test increased": 4.44, "liver injury": 7.74, "loose body in joint": 178.5, "loss of personal independence in daily activities": 4.47, "loss of therapeutic response": 6.01, "lower limb fracture": 2.9, "lower respiratory tract infection": 4.29, "lupus vulgaris": 411.14, "lupus-like syndrome": 5.7, "macular degeneration": 9.75, "maternal exposure during pregcy": 7.89, "mean cell haemoglobin decreased": 10.53, "mobility decreased": 4.58, "multiple-drug resistance": 8.83, "muscle injury": 18.8, "musculoskeletal disorder": 3.4, "musculoskeletal pain": 4.75, "musculoskeletal stiffness": 3.77, "nodule": 3.94, "obesity": 9.11, "off label use": 2.58, "onychomadesis": 12.06, "onychomycosis": 10.65, "oral discomfort": 2.98, "osteoarthritis": 4.61, "osteomyelitis": 3.08, "osteoporotic fracture": 19.51, "panniculitis": 14.62, "paradoxical drug reaction": 5.7, "pemphigus": 88.55, "pericarditis": 3.91, "peripheral venous disease": 13.07, "polyarthritis": 9.65, "prescribed overdose": 2.82, "prescribed underdose": 3.35, "procedural pain": 8.52, "proctitis": 14.48, "product use issue": 6.03, "psoriasis": 5.14, "psoriatic arthropathy": 22.08, "pulmonary fibrosis": 4.84, "pulmonary mass": 2.17, "pulmonary tuberculosis": 5.47, "pustular psoriasis": 7.3, "pyoderma gangrenosum": 17.2, "quality of life decreased": 2.2, "radiculopathy": 5.98, "red blood cell sedimentation rate abnormal": 46.92, "red blood cell sedimentation rate increased": 8.52, "retinitis": 24.53, "rheumatic fever": 105.3, "rheumatoid arthritis": 15.04, "rheumatoid factor positive": 101.42, "rheumatoid nodule": 16.69, "sacroiliitis": 29.4, "sciatica": 2.26, "sensitivity to weather change": 4.54, "sinusitis": 2.94, "skin infection": 2.44, "skin ulcer": 2.13, "sleep disorder due to general medical condition, insomnia type": 11.64, "small intestinal obstruction": 2.06, "spondyloarthropathy": 23.71, "steroid dependence": 70.88, "streptococcal infection": 5.15, "subcutaneous abscess": 3.35, "swelling": 4.14, "swollen joint count increased": 142.02, "synovitis": 31.89, "systemic lupus erythematosus": 23.59, "takayasu's arteritis": 38.71, "tenosynovitis": 9.2, "therapeutic product effect decreased": 14.73, "therapeutic product effect incomplete": 7.12, "therapy non-responder": 5.26, "treatment failure": 20.01, "type 2 diabetes mellitus": 3.84, "ulcer": 2.12, "uveitis": 2.67, "vaginal discharge": 2.95, "vaginal flatulence": 80.66, "wheelchair user": 4.96, "wound": 22.39, "wound infection": 3.25}